Deal watch: Novartis licenses GenVec's hearing loss programme.
D000818:Animals; D001709:Biotechnology / Q000191:economics*; D055808:Drug Discovery / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D015316:Genetic Therapy; D034381:Hearing Loss / Q000628:therapy*; D006801:Humans